During the diagnosis phase of pharmacotherapy, what are the three main areas of concern?

• A. Promoting therapeutic drug effects, minimizing adverse drug effects and toxicity, maximizing the patient's ability for self-care, including the knowledge, skills and resources necessary for safe and effective drug administration.
• B. Monitoring blood levels of all medications daily.
• C. Ensuring the patient adheres without education.
• D. Documenting medication administration times.

Answer: (A)

In pharmacotherapy, the diagnosis phase focuses on defining patient-centered goals for drug therapy that guide planning and actions. The three main concerns are to promote therapeutic drug effects so the treatment achieves the intended health outcomes, to minimize adverse drug effects and toxicity to protect the patient from harm, and to maximize the patient’s ability for self-care by ensuring they have the knowledge, skills, and resources needed for safe and effective drug administration. This framing helps the nurse identify what outcomes are expected, what risks must be prevented, and what education and support the patient needs to manage the medication successfully.

The other options don’t fit as the primary diagnostic focus. Daily monitoring of blood levels is a monitoring activity that applies only to specific drugs and isn’t the broad, overarching diagnosis goal. Expecting adherence without education undermines patient safety, since education is essential to promote adherence. Documenting medication administration times is part of implementation and documentation, not the diagnostic aims of pharmacotherapy.